It’s not easy to go from a nascent scientific concept to a fully-funded life sciences organization. In this web panel discussion, the panelists discussed the best ways to navigate this path successfully. The discussion provided examples of how executive teams can partner business with science in order to overcome stumbling blocks and achieve results. You'll hear real stories from experienced scientific founders who have been in the trenches from founding to funding to exit.Read More and View Recording
There is a lot of noise around artificial intelligence (AI) and how it is or isn’t changing the drug development landscape. One of the key benefits of AI is finding the signal in the noise...
Using suppliers is an excellent way to get access to skills and technology that aren’t available internally. However, using suppliers may also create wasted time and effort on the part of the company and the supplier. After both working with suppliers and being a supplier, Maren Nelson has learned some key factors to consider...
March 31, 2016
After both working with suppliers and being a supplier, Maren Nelson has learned some key factors to consider at the beginning of a relationship that can help achieve the desired result. This webinar educates on what often gets overlooked when rushing to select a supplier, often leading to wasted time and effort.
February 26, 2017
The past five years have challenging periods for raising capital in the biotechnology industry, especially for early-stage companies. Numerous factors, including a challenging FDA environment upon NDA submission, long timelines to approval and the high rate of drug failure, have contributed to a dim venture capitalist view of the sector’s prospects. As a result...
When entering due diligence, it's important to know what information to share and when to share it to ensure a timely process.
This due diligence checklist - which is easy to upload to a virtual data room - is designed to make sure you share or seek the appropriate information during partnering, licensing, M&A or an asset sale.
April 21, 2016
In this webinar, Scott Jordan, CEO of S. Jordan Associates and Co-Founder of HealthiosXchange, summarizes the impact of FinTECH (Financial Technology) and Legislation (JOBS Act) on financing, licensing, and “exit” (IPOs) activity in the healthcare industry.
September 2, 2015
An IP strategy is crucial for a company driven by technological innovation. In this web panel discussion, our panel of experienced women share their thoughts on best practices for effectively sharing IP, analyzing potential collaborations, avoiding pitfalls, and maximizing an invention’s ROI.